Comprehensive analysis of tumor microenvironment cytokines in Waldenstrom macroglobulinemia identifies CCL5 as a novel modulator of IL-6 activity
about
Factors regulating immunoglobulin production by normal and disease-associated plasma cellsThe bone marrow microenvironment in Waldenström macroglobulinemiaMature IgM-expressing plasma cells sense antigen and develop competence for cytokine production upon antigenic challengeSelective androgen receptor modulators (SARMs) negatively regulate triple-negative breast cancer growth and epithelial:mesenchymal stem cell signalingMesenchymal stem cell-induced doxorubicin resistance in triple negative breast cancer.Elevated soluble IL-2Rα, IL-8, and MIP-1β levels are associated with inferior outcome and are independent of MIPI score in patients with mantle cell lymphomaAntagonism of cannabinoid receptor 2 pathway suppresses IL-6-induced immunoglobulin IgM secretion.Modulation of the IL-6 Receptor α Underlies GLI2-Mediated Regulation of Ig Secretion in Waldenström Macroglobulinemia Cells.Comprehensive serum cytokine analysis identifies IL-1RA and soluble IL-2Rα as predictors of event-free survival in T-cell lymphomaCisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells.Single-cell protein secretomic signatures as potential correlates to tumor cell lineage evolution and cell-cell interaction.Cancer prevention and therapy through the modulation of the tumor microenvironment.Candidate genes of Waldenström's macroglobulinemia: current evidence and research.Critical role of the WASF3 gene in JAK2/STAT3 regulation of cancer cell motility.Transgenic mouse model of IgM+ lymphoproliferative disease mimicking Waldenström macroglobulinemia.Activation of TAK1 by MYD88 L265P drives malignant B-cell Growth in non-Hodgkin lymphoma.Molecular pathogenesis of Waldenstrom's macroglobulinemia.Waldenström macroglobulinaemia: the key questions.Novel treatment options for Waldenström macroglobulinemiaWaldenström macroglobulinemia: from biology to treatment.Siltuximab and hematologic malignancies. A focus in non Hodgkin lymphoma.TCL1 expression patterns in Waldenström macroglobulinemia.Constitutive activation of STAT5A and STAT5B regulates IgM secretion in Waldenstrom's macroglobulinemia.CXCL13 levels are elevated in patients with Waldenström macroglobulinemia, and are predictive of major response to ibrutinib.Novel Molecular Mechanism of Regulation of CD40 Ligand by the Transcription Factor GLI2.Elevated RANTES level is associated with metabolic syndrome and correlated with activated platelets associated markers in healthy younger men.Loss of TNFAIP3 enhances MYD88-driven signaling in non-Hodgkin lymphomaSoluble PD-1 ligands regulate T-cell function in Waldenstrom macroglobulinemia
P2860
Q27021855-C4CBDBCB-831A-4916-A748-F09B9C624728Q27028214-421866A9-1826-4C84-B17A-68580C22FFBAQ28817598-78533383-C6AD-419A-B2A9-22685AFA28F8Q33966915-18DE3587-9A45-43E6-9E0A-40A6721CE9CCQ34012393-A33F545D-BCF1-4164-94E6-CA5E89823517Q34626318-44E34D3E-BDC6-420F-9229-D2F939748D04Q35184435-E05E29ED-25AB-4D76-AAD4-D1D5A1A2DE62Q36031506-BA27B546-1FBF-419A-93B7-F1B2A51A5E71Q36384484-ED461236-B6AA-489A-87A9-9E415CB32E2BQ36454593-8E1CB78C-2A9C-4DF6-B668-0C526D103F91Q36589648-48C47059-FDF5-47CE-A1DD-50C00C37D95BQ37058267-9132B263-9662-42F1-B1DF-047DC31BDED4Q37074275-60BF36FC-D74F-4A76-AD72-EDAE8960077EQ37151653-98E1D071-E538-4EF4-91B0-2708D2C468A2Q37490002-3C731676-D517-40B9-B86C-7F7538FAA79EQ37621361-4E5483DB-7AF8-4745-B9B0-A4376E52AD47Q38024773-DD19A5C7-3B4A-4BED-A89F-57851E274461Q38104808-AB8E6C81-BCBB-440F-8677-205458C5AA4CQ38167433-8E89AFDB-65CC-4996-81F1-CDEB6EA60E3EQ38176969-DBE89FFB-3857-422D-AD62-676E8CFDFB94Q38763837-00BD0E0D-ADEC-4151-94E1-C8D6D35EFBBCQ41192923-226CAEB4-6EF3-4C11-A3A3-3DB3E9BA3DA4Q41956333-EE45D636-8BFB-4AEC-94E5-56DCAF07BB7DQ43272252-00F674E0-75C0-4181-9875-E77C6F45E8AFQ48210066-36D7CE9C-31A0-4756-BE45-521D6031F44DQ51026913-94E3CBBB-E95A-4635-B31D-39F8F2F427D2Q57287569-795953EA-779A-498A-8AE6-B79C850D8616Q58786066-7BFC1EF9-6A40-4D7D-A8F2-4370816D338D
P2860
Comprehensive analysis of tumor microenvironment cytokines in Waldenstrom macroglobulinemia identifies CCL5 as a novel modulator of IL-6 activity
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Comprehensive analysis of tumo ...... vel modulator of IL-6 activity
@ast
Comprehensive analysis of tumo ...... vel modulator of IL-6 activity
@en
type
label
Comprehensive analysis of tumo ...... vel modulator of IL-6 activity
@ast
Comprehensive analysis of tumo ...... vel modulator of IL-6 activity
@en
prefLabel
Comprehensive analysis of tumo ...... vel modulator of IL-6 activity
@ast
Comprehensive analysis of tumo ...... vel modulator of IL-6 activity
@en
P2093
P2860
P1433
P1476
Comprehensive analysis of tumo ...... vel modulator of IL-6 activity
@en
P2093
Anne J Novak
Deanna M Grote
Luciana L Almada
Lucy S Hodge
Martin E Fernandez-Zapico
Sherine F Elsawa
Stephen M Ansell
Steven C Ziesmer
Thomas E Witzig
P2860
P304
P356
10.1182/BLOOD-2011-04-351742
P407
P577
2011-09-14T00:00:00Z